Delivra Health Brands Inc. (TSXV:DHB)
0.0850
-0.0050 (-5.56%)
Sep 2, 2026, 2:48 PM EST
Delivra Health Brands Ratios and Metrics
Market cap in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 3 | 6 | 11 | 3 | 8 | 27 | |
Market Cap Growth | -63.83% | -47.14% | 333.13% | -66.67% | -71.43% | 29.82% |
Enterprise Value | 2 | 5 | 10 | 1 | 8 | 22 |
Last Close Price | 0.09 | 0.18 | 0.35 | 0.10 | 0.30 | 1.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | 12.49 | - | - | - |
Forward PE | - | 63.00 | 63.00 | 63.00 | 63.00 | 63.00 |
PS Ratio | 0.24 | 0.43 | 0.88 | 0.26 | 0.93 | 3.33 |
PB Ratio | 0.90 | 1.36 | 2.11 | 0.75 | 2.25 | 2.66 |
P/TBV Ratio | 0.90 | 1.36 | 2.73 | 2.74 | - | 6.72 |
P/FCF Ratio | - | - | 14.47 | - | - | - |
P/OCF Ratio | - | - | 14.47 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 0.21 | 0.34 | 0.77 | 0.15 | 0.98 | 2.73 |
EV/EBITDA Ratio | - | 10.58 | 15.96 | - | - | - |
EV/FCF Ratio | - | - | 12.64 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.79 | 0.50 | 0.39 | 0.58 | 0.63 | 0.22 |
Debt / EBITDA Ratio | - | 4.95 | 3.38 | - | - | - |
Debt / FCF Ratio | - | - | 2.68 | - | - | - |
Net Debt / Equity Ratio | -0.10 | -0.28 | -0.42 | -0.23 | 0.30 | -0.30 |
Net Debt / EBITDA Ratio | 0.48 | -2.78 | -3.63 | 23.49 | -0.25 | 0.42 |
Net Debt / FCF Ratio | 0.94 | 1.58 | -2.87 | 0.71 | -0.22 | 0.31 |
Asset Turnover | 1.43 | 1.36 | 1.20 | 0.88 | 0.53 | 0.21 |
Inventory Turnover | 3.10 | 3.11 | 3.20 | 2.22 | 2.46 | 1.04 |
Quick Ratio | 2.24 | 1.87 | 2.33 | 1.00 | 0.43 | 1.01 |
Current Ratio | 3.29 | 2.69 | 2.85 | 1.45 | 1.14 | 1.36 |
Return on Equity (ROE) | -28.27% | -25.23% | 20.41% | -5.44% | -105.00% | -97.41% |
Return on Assets (ROA) | -7.61% | -5.35% | -4.30% | -7.69% | -24.52% | -15.05% |
Return on Capital Employed (ROCE) | -19.30% | -13.90% | -10.20% | -26.80% | -119.20% | -78.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -38.05% | -20.58% | 8.01% | -7.28% | -92.48% | -107.59% |
FCF Yield | -12.23% | -13.04% | 6.91% | -43.07% | -58.73% | -36.49% |
Buyback Yield / Dilution | 5.46% | -9.44% | -13.08% | - | -11.80% | -5.06% |